Your browser doesn't support javascript.
loading
In vitro patient-derived 3D mesothelioma tumor organoids facilitate patient-centric therapeutic screening.
Mazzocchi, Andrea R; Rajan, Shiny A P; Votanopoulos, Konstantinos I; Hall, Adam R; Skardal, Aleksander.
Afiliación
  • Mazzocchi AR; Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Medical Center, Winston-Salem, NC, 27101, USA.
  • Rajan SAP; Virginia Tech-Wake Forest School of Biomedical Engineering and Sciences, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC, 27157, USA.
  • Votanopoulos KI; Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Medical Center, Winston-Salem, NC, 27101, USA.
  • Hall AR; Virginia Tech-Wake Forest School of Biomedical Engineering and Sciences, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC, 27157, USA.
  • Skardal A; Department of Surgery-Surgical Oncology, Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC, 27157, USA. kvotanop@wakehealth.edu.
Sci Rep ; 8(1): 2886, 2018 02 13.
Article en En | MEDLINE | ID: mdl-29440675

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Ensayos de Selección de Medicamentos Antitumorales / Organoides / Ingeniería Celular / Mesotelioma Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Límite: Humans Idioma: En Revista: Sci Rep Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Ensayos de Selección de Medicamentos Antitumorales / Organoides / Ingeniería Celular / Mesotelioma Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Límite: Humans Idioma: En Revista: Sci Rep Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos